Newborn screening initiative
This article was originally published in The Gray Sheet
Executive Summary
Healthcare facilities would be able to purchase tandem mass spectrometry systems that test for more newborn genetic and metabolic disorders at lower cost under legislation to be introduced within the next several weeks by Sens. Mike DeWine (R-Ohio) and Chris Dodd (D-Conn.). A General Accounting Office report requested by the senators finds that a majority of states screen for eight or fewer diseases and that "most states spend $20-40 per newborn on screening, most of which is paid for by out-of-pocket screening fees," Dodd's office notes in an April 16 release...